Q10

ICH Q10 Overview

  • Current Step: 4 (recommended for adoption on 4 June 2008).

  • Purpose: Establish a model for an effective pharmaceutical quality system (PQS).

  • Compliance: Does not create new regulations, supports current Good Manufacturing Practice (GMP) standards.

Pharmaceutical Quality System (PQS)

  • Definition: Comprehensive model integrating ISO quality management concepts with GMP.

  • Scope: Applies throughout the pharmaceutical product lifecycle (development to discontinuation).

ICH Q10 Objectives

  • Achieve Product Realisation: Deliver products meeting quality attributes for patients and authorities.

  • Maintain a State of Control: Use effective monitoring systems to assure process capability.

  • Facilitate Continual Improvement: Identify and implement improvements in quality and processes.

Key Components

  1. Management Responsibility: Leadership must commit to quality and system effectiveness.

  2. Quality Policy: Senior management establishes an aligned quality policy.

  3. Quality Planning: Set, communicate, and monitor quality objectives.

  4. Resource Management: Ensure adequate resources for implementing PQS.

Continual Improvement Framework

  • Lifecycle Stage Goals:

    • Pharmaceutical Development: Design for consistent product quality.

    • Technology Transfer: Ensure knowledge is effectively shared.

    • Commercial Manufacturing: Maintain quality control in production.

    • Product Discontinuation: Manage product closure and reporting responsibilities.

Monitoring and Management Systems

  • Process Performance Monitoring: Establish systems to assure consistent quality.

  • CAPA System: Implement corrective actions for non-conformities.

  • Change Management System: Process for evaluating and documenting changes.

  • Management Review: Regular assessments of system effectiveness and quality performance.

Enablers

  • Knowledge Management: Systematic approach to managing product and process knowledge.

  • Quality Risk Management: Proactively identify and control quality-related risks throughout the lifecycle.

Conclusion

  • The ICH Q10 guideline aims to enhance the quality and availability of medicines, promote innovation, and ensure consistent product quality across the pharmaceutical industry.